Fendiline
![]() | |
| Gene therapy | |
|---|---|
| Clinical data | |
| ATC code | |
| Physiological data | |
| Legal status | |
| Pharmacokinetic data | |
| Identifiers | |
| |
| CAS Number | |
| PubChem Template:Abbreviation | |
| UNII | |
| KEGG | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C23H25N |
| Molar mass | 315.4513 |
| 3D model (JSmol) | |
| |
| (verify) | |
|
WikiDoc Resources for Fendiline |
|
Articles |
|---|
|
Most recent articles on Fendiline |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Fendiline at Clinical Trials.gov Clinical Trials on Fendiline at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Fendiline
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Fendiline Discussion groups on Fendiline Directions to Hospitals Treating Fendiline Risk calculators and risk factors for Fendiline
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Fendiline |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Fendiline is a calcium channel blocker.
It is nonselective.[1]
